An Insidious Clinical Picture: Optic Nerve Involvement in Patients with COVID-19
dc.contributor.author | Ocak, Ozgul | |
dc.contributor.author | Şahin, Erkan Melih | |
dc.contributor.author | Sener, Alper | |
dc.contributor.author | Ocak, Baris | |
dc.date.accessioned | 2025-01-27T21:20:04Z | |
dc.date.available | 2025-01-27T21:20:04Z | |
dc.date.issued | 2022 | |
dc.department | Çanakkale Onsekiz Mart Üniversitesi | |
dc.description.abstract | Objective: Many neurological symptoms due to central nervous system, peripheral nervous system and musculoskeletal system damage have been reported in more than a third of patients with coronavirus disease-2019 (COVID-19). Although optic neuritis has been reported in patients with COVID-19, they are extremely rare. The aim of this study was screening optic nerve involvement in COVID-19 with visual evoked potential (VEP) in asymptomatic patients without a history of visual impairment. Materials and Methods: Pattern reversal VEP measurements were made in 101 adult patients with COVID-19 without a history of visual impairment after they completed COVID-19 treatments and the quarantine period. VEPs were recorded with the 4-channel electromyography-evoked device in a dark room. P100 latencies and amplitudes were analyzed by the same neurologist. Results: A total of 34 (33.7%) patients had P100 latency prolongation. There was no significant difference in terms of gender, age or outpatient/inpatient treatment status. There was no significant correlation between the time of polymerase chain reaction diagnosis and VEP values. Conclusion: Contrary to previous studies, asymptomatic optic nerve involvement after COVID-19 was detected by VEP measurements. Prolongation of P100 latency shows the probable linkage between COVID-19 virus and angiotensin converting enzyme 2 receptors in human eyes. | |
dc.identifier.doi | 10.4274/tnd.2022.67026 | |
dc.identifier.endpage | 161 | |
dc.identifier.issn | 1301-062X | |
dc.identifier.issn | 1309-2545 | |
dc.identifier.issue | 3 | |
dc.identifier.scopus | 2-s2.0-85150371049 | |
dc.identifier.scopusquality | Q4 | |
dc.identifier.startpage | 158 | |
dc.identifier.trdizinid | 1173607 | |
dc.identifier.uri | https://doi.org/10.4274/tnd.2022.67026 | |
dc.identifier.uri | https://search.trdizin.gov.tr/tr/yayin/detay/1173607 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12428/28810 | |
dc.identifier.volume | 28 | |
dc.identifier.wos | WOS:000916443200006 | |
dc.identifier.wosquality | N/A | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | TR-Dizin | |
dc.language.iso | en | |
dc.publisher | Galenos Publ House | |
dc.relation.ispartof | Turkish Journal of Neurology | |
dc.relation.publicationcategory | info:eu-repo/semantics/openAccess | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.snmz | KA_WoS_20250125 | |
dc.subject | COVID-19 virus infection | |
dc.subject | optic nerve | |
dc.subject | VEP | |
dc.title | An Insidious Clinical Picture: Optic Nerve Involvement in Patients with COVID-19 | |
dc.title.alternative | Sinsi Bir Klinik Tablo: COVID-19’lu Hastalarda Optik Sinir Tutulumu | |
dc.type | Article |